Company / Free Cash Flow
Xenetic Biosciences, Inc. Free Cash Flow History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$1.5M
FY2018
5-year range
-
FY2016-FY2018
Trend
+116.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$5M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2018.
Improved from -$5M to $1M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, free cash flow increased 116.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $1.5M | +116.9% |
| FY2017 | -$8.8M | -66.0% |
| FY2016 | -$5.3M | +13.5% |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026